Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
S*BIO
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with histologically documented diagnosis of one of the following lymphoid malignancies:
Hodgkin Lymphoma;
Mantle Cell Lymphoma;
Indolent Lymphoma (including follicular lymphoma, lymphoplasmacytic lymphoma, marginal zone lymphoma and small lymphocytic lymphoma);
Patients must have received at least one prior treatment regimen; patients with Hodgkin Lymphoma must have received an autologous stem cell transplant, refused or been deemed ineligible for stem cell transplant;
Able to understand and willing to sign the informed consent form.
You may not be if
Any histology other than Hodgkin Lymphoma, Mantle Cell Lymphoma or Indolent Lymphoma;
History of or active Central Nervous System (CNS) malignancy;
Active graft-versus-host disease (GVHD);
Clareo Health | A Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies
